Wafik El-Deiry: ‘Tremendous Uncertainty’ For Cancer Research in US
Wafik El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University, shared a post on X:
“In my opinion, titrated regulation and molecular kill switches might avoid political action here.
Jay Bhattacharya last year said the pseudouridine-modified mRNA vaccines produce proteins whose dose and biodistribution are unknown.
Surely as the field of gene therapy did decades ago, we can engineer off-switches and other safeguards that science can deliver. Research and trials should proceed to address safety concerns. There are also exciting peptide vaccines that avoid mRNA.
But mRNA should be studied and because it looks promising, it should be made safer as far as how it is handled by the body.
There is a general need to keep track of the positive benefit while minimizing any downside towards the host.
‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines.”
More posts featuring Wafik El-Deiry.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023